These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 38506227)

  • 21. Pharmacologically upregulated carcinoembryonic antigen-expression enhances the cytolytic activity of genetically-modified chimeric antigen receptor NK-92MI against colorectal cancer cells.
    Shiozawa M; Chang CH; Huang YC; Chen YC; Chi MS; Hao HC; Chang YC; Takeda S; Chi KH; Wang YS
    BMC Immunol; 2018 Aug; 19(1):27. PubMed ID: 30075754
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Carcinoembryonic antigen-producing cell-specific oncolytic adenovirus, OV798, for colorectal cancer therapy.
    Li Y; Chen Y; Dilley J; Arroyo T; Ko D; Working P; Yu DC
    Mol Cancer Ther; 2003 Oct; 2(10):1003-9. PubMed ID: 14578465
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Texture analysis of (125)I-A5B7 anti-CEA antibody SPECT differentiates metastatic colorectal cancer model phenotypes and anti-vascular therapy response.
    Rajkumar V; Goh V; Siddique M; Robson M; Boxer G; Pedley RB; Cook GJ
    Br J Cancer; 2015 Jun; 112(12):1882-7. PubMed ID: 25989271
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Combination of antibody targeting and PTD-mediated intracellular toxin delivery for colorectal cancer therapy.
    Shin MC; Zhang J; Ah Min K; Lee K; Moon C; Balthasar JP; Yang VC
    J Control Release; 2014 Nov; 194():197-210. PubMed ID: 25204286
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Safety and effectiveness of SGM-101, a fluorescent antibody targeting carcinoembryonic antigen, for intraoperative detection of colorectal cancer: a dose-escalation pilot study.
    Boogerd LSF; Hoogstins CES; Schaap DP; Kusters M; Handgraaf HJM; van der Valk MJM; Hilling DE; Holman FA; Peeters KCMJ; Mieog JSD; van de Velde CJH; Farina-Sarasqueta A; van Lijnschoten I; Framery B; Pèlegrin A; Gutowski M; Nienhuijs SW; de Hingh IHJT; Nieuwenhuijzen GAP; Rutten HJT; Cailler F; Burggraaf J; Vahrmeijer AL
    Lancet Gastroenterol Hepatol; 2018 Mar; 3(3):181-191. PubMed ID: 29361435
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fluorophore-conjugated anti-CEA antibody for the intraoperative imaging of pancreatic and colorectal cancer.
    Kaushal S; McElroy MK; Luiken GA; Talamini MA; Moossa AR; Hoffman RM; Bouvet M
    J Gastrointest Surg; 2008 Nov; 12(11):1938-50. PubMed ID: 18665430
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Carcinoembryonic antigen directed herpes viral oncolysis improves selectivity and activity in colorectal cancer.
    Reinblatt M; Pin RH; Fong Y
    Surgery; 2004 Sep; 136(3):579-84. PubMed ID: 15349105
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of CEA-targeting Nanoparticles for Drug Delivery in Colorectal Cancer.
    Sousa AR; Oliveira MJ; Sarmento B
    J Pharmacol Exp Ther; 2019 Sep; 370(3):657-670. PubMed ID: 30670480
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fully human IgG and IgM antibodies directed against the carcinoembryonic antigen (CEA) Gold 4 epitope and designed for radioimmunotherapy (RIT) of colorectal cancers.
    Garambois V; Glaussel F; Foulquier E; Ychou M; Pugnière M; Luo RX; Bezabeh B; Pèlegrin A
    BMC Cancer; 2004 Oct; 4():75. PubMed ID: 15488142
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Physiologically Based Modeling of the Pharmacokinetics of "Catch-and-Release" Anti-Carcinoembryonic Antigen Monoclonal Antibodies in Colorectal Cancer Xenograft Mouse Models.
    Polli JR; Engler FA; Balthasar JP
    J Pharm Sci; 2019 Jan; 108(1):674-691. PubMed ID: 30321546
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Multimodal CEA-Targeted Image-Guided Colorectal Cancer Surgery using
    de Gooyer JM; Elekonawo FMK; Bos DL; van der Post RS; Pèlegrin A; Framery B; Cailler F; Vahrmeijer AL; de Wilt JHW; Rijpkema M
    Clin Cancer Res; 2020 Nov; 26(22):5934-5942. PubMed ID: 32900795
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Novel Carcinoembryonic-Antigen-(CEA)-Specific Pretargeting System to Assess Tumor Cell Viability after Irradiation of Colorectal Cancer Cells.
    Meller B; Rave-Fränck M; Breunig C; Schirmer M; Baehre M; Nadrowitz R; Liersch T; Meller J
    Strahlenther Onkol; 2011 Feb; 187(2):120-6. PubMed ID: 21271227
    [TBL] [Abstract][Full Text] [Related]  

  • 33. PET imaging of colorectal cancer in xenograft-bearing mice by use of an 18F-labeled T84.66 anti-carcinoembryonic antigen diabody.
    Cai W; Olafsen T; Zhang X; Cao Q; Gambhir SS; Williams LE; Wu AM; Chen X
    J Nucl Med; 2007 Feb; 48(2):304-10. PubMed ID: 17268029
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chlorin Nanoparticles for Tissue Diagnostics and Photodynamic Therapy.
    Scalfi-Happ C; Zhu Z; Graefe S; Wiehe A; Ryabova A; Loschenov V; Wittig R; Steiner RW
    Photodiagnosis Photodyn Ther; 2018 Jun; 22():106-114. PubMed ID: 29567384
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rapid tumor-labeling kinetics with a site-specific near-infrared anti-CEA nanobody in a patient-derived orthotopic xenograft mouse model of colon cancer.
    Lwin TM; Turner MA; Amirfakhri S; Nishino H; Debie P; Cosman BC; Hoffman RM; Hernot S; Bouvet M
    J Surg Oncol; 2021 Dec; 124(7):1121-1127. PubMed ID: 34309885
    [TBL] [Abstract][Full Text] [Related]  

  • 36. EGFR-targeted liposomal nanohybrid cerasomes: theranostic function and immune checkpoint inhibition in a mouse model of colorectal cancer.
    Li Y; Du Y; Liang X; Sun T; Xue H; Tian J; Jin Z
    Nanoscale; 2018 Sep; 10(35):16738-16749. PubMed ID: 30156250
    [TBL] [Abstract][Full Text] [Related]  

  • 37. ZKSCAN3 Facilitates Liver Metastasis of Colorectal Cancer Associated with CEA-expressing Tumor.
    Kim CW; Roh SA; Tak KH; Koh BM; Ha YJ; Cho DH; Kim SY; Kim YS; Kim JC
    Anticancer Res; 2016 May; 36(5):2397-406. PubMed ID: 27127149
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Significant Therapeutic Efficacy with Combined Radioimmunotherapy and Cetuximab in Preclinical Models of Colorectal Cancer.
    Vassileva V; Rajkumar V; Mazzantini M; Robson M; Badar A; Sharma S; Årstad E; Hochhauser D; Lythgoe MF; Kinghorn J; Boxer GM; Pedley RB
    J Nucl Med; 2015 Aug; 56(8):1239-45. PubMed ID: 26045312
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Photochemical internalization (PCI)-mediated enhancement of bleomycin cytotoxicity by liposomal mTHPC formulations in human head and neck cancer cells.
    Peng W; Samplonius DF; de Visscher S; Roodenburg JL; Helfrich W; Witjes MJ
    Lasers Surg Med; 2014 Oct; 46(8):650-8. PubMed ID: 25174329
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Targeted killing of colorectal cancer cell lines by a humanised IgG1 monoclonal antibody that binds to membrane-bound carcinoembryonic antigen.
    Conaghan P; Ashraf S; Tytherleigh M; Wilding J; Tchilian E; Bicknell D; Mortensen NJ; Bodmer W
    Br J Cancer; 2008 Apr; 98(7):1217-25. PubMed ID: 18349843
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.